If you take a b-cell depleting drug (ocrevus, rituximab kesimpta) for multiple sclerosis while breastfeeding, will your infant's b-cell be affected? In this study (n=10), only one infant had b-cell counts below the 5th percentile. pubmed.ncbi.nlm.nih.gov/42226810/
